Immunomodulators in Inflammatory Bowel Disease: An Emerging Role for Biologic Agents
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunomodulators in Inflammatory Bowel Disease: An Emerging Role for Biologic Agents
Authors
Keywords
Inflammatory Bowel Disease, Ulcerative Colitis, Infliximab, Th17 Cell, Etanercept
Journal
BIODRUGS
Volume 27, Issue 6, Pages 585-590
Publisher
Springer Nature
Online
2013-06-07
DOI
10.1007/s40259-013-0045-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting T-cell migration in inflammatory bowel disease
- (2013) J. Marsal et al. JOURNAL OF INTERNAL MEDICINE
- Evidence from Genetics for a Role of Autophagy and Innate Immunity in IBD Pathogenesis
- (2012) Miles Parkes DIGESTIVE DISEASES
- Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
- (2012) Paul Rutgeerts et al. GASTROENTEROLOGY
- Endoscopic improvement of mucosal lesions in patients with moderate to severe ileocolonic Crohn's disease following treatment with certolizumab pegol
- (2012) Xavier Hébuterne et al. GUT
- Mucosal healing in inflammatory bowel diseases: a systematic review
- (2012) Markus F Neurath et al. GUT
- Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patients
- (2012) Adam Girardin et al. INTERNATIONAL JOURNAL OF CANCER
- Risk of Infection and Prevention in Pediatric Patients With IBD
- (2012) Gigi Veereman-Wauters et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Review article: remission rates achievable by current therapies for inflammatory bowel disease
- (2011) L. Peyrin-Biroulet et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- New therapies for inflammatory bowel disease: from the bench to the bedside
- (2011) Silvio Danese GUT
- Use of biological molecules in the treatment of inflammatory bowel disease
- (2011) O. H. Nielsen et al. JOURNAL OF INTERNAL MEDICINE
- Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease
- (2011) Kara Bradford WORLD JOURNAL OF GASTROENTEROLOGY
- Review article: the role of non-biological drugs in refractory inflammatory bowel disease
- (2010) S. C. Ng et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
- (2010) R. DUCHMANN et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease
- (2010) H.-C. REINECKER et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Thiopurines in Crohn's disease, is there something new?
- (2010) Pal Miheller et al. Expert Opinion on Drug Metabolism & Toxicology
- A human gut microbial gene catalogue established by metagenomic sequencing
- (2010) Junjie Qin et al. NATURE
- Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
- (2009) Josh Marehbian et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- IL-17 and Th17 Cells
- (2009) Thomas Korn et al. Annual Review of Immunology
- Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis
- (2009) Corey A. Siegel et al. Clinical Gastroenterology and Hepatology
- Intestinal Effector T Cells in Health and Disease
- (2009) Craig L. Maynard et al. IMMUNITY
- Dendritic cells in intestinal homeostasis and disease
- (2009) Maria Rescigno et al. JOURNAL OF CLINICAL INVESTIGATION
- European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
- (2009) J.F. Rahier et al. Journal of Crohns & Colitis
- Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
- (2009) Laurent Beaugerie et al. LANCET
- Treatment of Active Crohn's Disease With MLN0002, a Humanized Antibody to the α4β7 Integrin
- (2008) Brian G. Feagan et al. Clinical Gastroenterology and Hepatology
- Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials
- (2008) Laurent Peyrin–Biroulet et al. Clinical Gastroenterology and Hepatology
- Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases
- (2008) C. D. Packey et al. JOURNAL OF INTERNAL MEDICINE
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
- Nonimmune cells in inflammatory bowel disease: from victim to villain
- (2008) Silvio Danese TRENDS IN IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now